These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 18083531)

  • 1. Immune response to biologic scaffold materials.
    Badylak SF; Gilbert TW
    Semin Immunol; 2008 Apr; 20(2):109-16. PubMed ID: 18083531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic Scaffolds.
    Costa A; Naranjo JD; Londono R; Badylak SF
    Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 28320826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The host response to allogeneic and xenogeneic biological scaffold materials.
    Keane TJ; Badylak SF
    J Tissue Eng Regen Med; 2015 May; 9(5):504-11. PubMed ID: 24668694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction.
    Badylak SF
    Transpl Immunol; 2004 Apr; 12(3-4):367-77. PubMed ID: 15157928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cell debris within biologic scaffolds upon the macrophage response.
    Londono R; Dziki JL; Haljasmaa E; Turner NJ; Leifer CA; Badylak SF
    J Biomed Mater Res A; 2017 Aug; 105(8):2109-2118. PubMed ID: 28263432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation.
    Wong ML; Wong JL; Vapniarsky N; Griffiths LG
    Biomaterials; 2016 Jun; 92():1-12. PubMed ID: 27031928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: factors that influence the host response.
    Badylak SF
    Ann Biomed Eng; 2014 Jul; 42(7):1517-27. PubMed ID: 24402648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Rodent Model to Evaluate the Tissue Response to a Biological Scaffold When Adjacent to a Synthetic Material.
    Dearth CL; Keane TJ; Scott JR; Daly KA; Badylak SF
    Tissue Eng Part A; 2015 Oct; 21(19-20):2526-35. PubMed ID: 26176992
    [TBL] [Abstract][Full Text] [Related]  

  • 9.  Extracellular Matrix-Based Biomaterials and Their Influence Upon Cell Behavior.
    Cramer MC; Badylak SF
    Ann Biomed Eng; 2020 Jul; 48(7):2132-2153. PubMed ID: 31741227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy.
    Wolf MT; Ganguly S; Wang TL; Anderson CW; Sadtler K; Narain R; Cherry C; Parrillo AJ; Park BV; Wang G; Pan F; Sukumar S; Pardoll DM; Elisseeff JH
    Sci Transl Med; 2019 Jan; 11(477):. PubMed ID: 30700576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomaterials: Foreign Bodies or Tuners for the Immune Response?
    Mariani E; Lisignoli G; Borzì RM; Pulsatelli L
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of COX1/2 alters the host response and reduces ECM scaffold mediated constructive tissue remodeling in a rodent model of skeletal muscle injury.
    Dearth CL; Slivka PF; Stewart SA; Keane TJ; Tay JK; Londono R; Goh Q; Pizza FX; Badylak SF
    Acta Biomater; 2016 Feb; 31():50-60. PubMed ID: 26612417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Th1/Th2 nature of concurrent immune responses to unrelated antigens can be independent.
    Ismail N; Bretscher PA
    J Immunol; 1999 Nov; 163(9):4842-50. PubMed ID: 10528185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix as a biological scaffold material: Structure and function.
    Badylak SF; Freytes DO; Gilbert TW
    Acta Biomater; 2009 Jan; 5(1):1-13. PubMed ID: 18938117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix-bound nanovesicles within ECM bioscaffolds.
    Huleihel L; Hussey GS; Naranjo JD; Zhang L; Dziki JL; Turner NJ; Stolz DB; Badylak SF
    Sci Adv; 2016 Jun; 2(6):e1600502. PubMed ID: 27386584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo degradation of 14C-labeled porcine dermis biologic scaffold.
    Carey LE; Dearth CL; Johnson SA; Londono R; Medberry CJ; Daly KA; Badylak SF
    Biomaterials; 2014 Sep; 35(29):8297-304. PubMed ID: 24997479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantitative method for evaluating the degradation of biologic scaffold materials.
    Gilbert TW; Stewart-Akers AM; Badylak SF
    Biomaterials; 2007 Jan; 28(2):147-50. PubMed ID: 16949150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of terminal sterilization on the material properties and in vivo remodeling of a porcine dermal biologic scaffold.
    Dearth CL; Keane TJ; Carruthers CA; Reing JE; Huleihel L; Ranallo CA; Kollar EW; Badylak SF
    Acta Biomater; 2016 Mar; 33():78-87. PubMed ID: 26826528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocols for the preparation and characterization of decellularized tissue and organ scaffolds for tissue engineering.
    Hsieh DJ; Srinivasan P; Yen KC; Yeh YC; Chen YJ; Wang HC; Tarng YW
    Biotechniques; 2021 Feb; 70(2):107-115. PubMed ID: 33307815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenoreactivity of fetal and neonatal baboon intracellular antibody against the pig.
    Xu H; Gundry SR; Bailey LL
    Transplant Proc; 2000 Aug; 32(5):869-71. PubMed ID: 10936251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.